MIVU:XETRA:XETRA-Amundi Index Solutions MSCI USA Minimum Volatility Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 84.91

Change

-0.15 (-0.18)%

Market Cap

USD 0.30B

Volume

23.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.22 (+0.43%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.07 (+0.44%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.10 (+0.38%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.11 (+0.40%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.21 (+0.86%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-1.10 (-0.71%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+1.14 (+0.83%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.21 (+0.47%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.24 (+0.48%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+4.85 (+0.98%)

USD 80.38B

ETFs Containing MIVU:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.97% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.97% 75% C 73% C
Trailing 12 Months  
Capital Gain 16.52% 67% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.52% 67% D+ 68% D+
Trailing 5 Years  
Capital Gain 50.58% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.58% 72% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.37% 67% D+ 65% D
Dividend Return 7.37% 66% D+ 62% D
Total Return N/A 65% D 57% F
Risk Return Profile  
Volatility (Standard Deviation) 10.34% 61% D- 69% C-
Risk Adjusted Return 71.22% 89% A- 89% A-
Market Capitalization 0.30B 57% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike